Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.38%
SPX
+0.88%
IXIC
+1.31%
FTSE
+0.61%
N225
+1.03%
AXJO
+0.39%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Stocks
Health Care
vnda
Vanda Pharmaceuticals
NASDAQ: VNDA
+0.08 (+1.27%)
6.755
USD
At close at Dec 19, 21:38 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Vanda Pharmaceuticals News

prnewswire.com

Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Fda Approval, Health Care & Hospitals from prnewswire.com
6 days ago
prnewswire.com

FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness

Feature Image for interests on Fda Approval, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com
16 days ago
benzinga.com

FDA Fast-Tracks Vanda's Motion Sickness Drug Review After Leadership Shake-Up

Feature Image for interests on Biotech, Fda, General, Health Care from benzinga.com
23 days ago
prnewswire.com

Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness

Feature Image for interests on Fda Approval, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com
23 days ago
benzinga.com

Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat

Feature Image for interests on Andrew Tsai, B Riley, Expert Ideas, Financial Services from benzinga.com
about 1 month ago
benzinga.com

Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients

Feature Image for interests on Biotech, Health Care, Healthcare, News from benzinga.com
about 1 month ago
prnewswire.com

Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting

Feature Image for interests on Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com
about 1 month ago
benzinga.com

Earnings Scheduled For October 29, 2025

Feature Image for interests on Basic Materials, Bzi-Ue, Communication Services, Consumer Cyclical from benzinga.com
about 2 months ago
benzinga.com

Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock

Feature Image for interests on Basic Materials, Cnbc, Energy, Financial Services from benzinga.com
about 2 months ago
cnbc.com

Cramer's Lighting Round: Apollo Global Management is a buy

Feature Image for interests on Basic Materials, Business, Energy, Financial Services from cnbc.com
about 2 months ago
Join our newsletter to keep up to date with us!

Latest Cashu News

publisher logo
Cashu

Vanda Pharmaceuticals Submits BLA for Imsidolimab, Targeting Rare Skin Condition GPP

3 days ago
publisher logo
Cashu

Vanda Pharmaceuticals Submits BLA for Innovative GPP Treatment, Imsidolimab

5 days ago
publisher logo
Cashu

Vanda Pharmaceuticals Submits BLA for Imsidolimab to Treat Generalized Pustular Psoriasis

7 days ago